ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
2.430
0.00 (0.00%)
At close: Sep 18, 2024, 4:00 PM
2.460
+0.030 (1.23%)
After-hours: Sep 18, 2024, 5:25 PM EDT

ZyVersa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-21.83-98.3-14.12-8.08-12.68
Depreciation & Amortization
0.020.010.010.010.01
Other Amortization
--0.040.320.29
Asset Writedown & Restructuring Costs
12.1693.33---
Stock-Based Compensation
0.921.193.584.143.68
Other Operating Activities
-0.4-7.56-0.05-0.440.49
Change in Accounts Payable
0.172.414.54-0.31-0.6
Change in Other Net Operating Assets
-0.460.191.12-0.713.71
Operating Cash Flow
-9.41-8.72-4.89-5.08-5.11
Long-Term Debt Issued
---5.231.69
Net Debt Issued (Repaid)
---5.231.69
Issuance of Common Stock
10.7419.08--3.02
Repurchase of Common Stock
--0.01---
Other Financing Activities
-1.2-2.42-0.1--0.14
Financing Cash Flow
9.315.961.875.234.56
Net Cash Flow
-0.11-2.76-3.020.15-0.55
Free Cash Flow
-9.41-8.72-4.89-5.08-5.11
Free Cash Flow Per Share
-21.26-89.44-74.56-2.10-75.66
Levered Free Cash Flow
-5.54-5.46-1.65-2.02-
Unlevered Free Cash Flow
-5.54-5.46-1.43-1.83-
Change in Net Working Capital
0.07-2.35-3.631.27-
Source: S&P Capital IQ. Standard template. Financial Sources.